Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dingjia Lei
Institutions:
China National Nuclear Corporation,
Chengdu Medical College
Observed institutions:
China National Nuclear Corporation,
Chengdu Medical College,
The Affiliated Yongchuan Hospital of Chongqing Medical University
ORCID:
0000-0002-9592-7970
Observed ORCID:
0000-0002-9592-7970
OpenAlex ID:
A5004508405
Risk of HBV reactivation in HCC patients undergoing combination therapy of PD-1 inhibitors and angiogenesis inhibitors in the antiviral era
2024
·
Rui Wang
, Guili Tan
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
9
PDF
The antiviral activity of tripartite motif protein 38 in hepatitis B virus replication and gene expression and its association with treatment responses during PEG-IFN-α antiviral therapy
2022
·
Haiying Luo
, Xiaoxia Hu
, et al.
·
Virology
·
9
PDF
Triple motif proteins 19 and 38 correlated with treatment responses and HBsAg clearance in HBeAg-negative chronic hepatitis B patients during peg-IFN-α therapy
2023
·
Haiying Luo
, Guili Tan
, et al.
·
Virology Journal
·
8
PDF
Think twice about IgG4 ‐related diseases before operating on hepatic masses
2022
·
Dingjia Lei
, Huating Luo
, et al.
·
Liver International
Show more works
View as search
Works count:
4
Citation count:
26
H-index:
3
I10-index:
Year
Topic
Type